FOXO TECHNOLOGIES INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
FOXO TECHNOLOGIES INC. (FOXO) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$7.64 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2023-05-11
- FOXO TECHNOLOGIES INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2023-03-31 was -$7.64M.
- FOXO TECHNOLOGIES INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2022-12-31 was -$18.32M.
- FOXO TECHNOLOGIES INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2022-09-30 was -$41.03M.
- FOXO TECHNOLOGIES INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2022-03-31 was -$12.37M.
- FOXO TECHNOLOGIES INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$95.25M.
- FOXO TECHNOLOGIES INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2021 was -$38.49M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 3 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 6 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 9 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|---|---|---|
| 2023-03-31 | -$7.64M 10-Q · filed 2023-05-11 | -$25.96M derived: sum of 2 quarters · filed 2023-05-11 | -$66.99M derived: sum of 3 quarters · filed 2023-05-11 | |
| 2022-12-31 | -$18.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$59.35M derived: sum of 2 quarters · filed 2023-03-31 | -$95.25M 10-K · filed 2023-03-31 | |
| 2022-09-30 | -$41.03M 10-Q · filed 2022-11-21 | -$76.93M 10-Q · filed 2022-11-21 | ||
| 2022-03-31 | -$12.37M 10-Q · filed 2023-05-11 | -$13.24M derived: sum of 2 quarters · filed 2023-05-11 | -$40.48M derived: sum of 3 quarters · filed 2023-05-11 | |
| 2021-12-31 | -$874.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$28.11M derived: sum of 2 quarters · filed 2023-03-31 | -$38.49M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$27.24M 10-Q · filed 2022-11-21 | -$37.61M 10-Q · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |